‘The Danger Is Still There’ ― As Omicron Lurks, Native Americans Are Wary of Boosters
Federal data shows that vaccination rates for American Indians and Alaska Natives were some of the highest in the nation, but tribes say resistance has slowed efforts to boost members.
Health Officials See Bright Future in Poop Surveillance
Sewage surveillance is proving so useful in mapping covid trends that many public health officials say it should become standard practice in tracking infectious diseases. Whether that happens will depend on the nation’s ability to make it viable in communities rich and poor.
Patients With Vulnerable Immune Systems Worry Vaccine Exemptions May Put Them in Peril
Montana’s governor pushed the state’s health workers to seek religious exemptions to a federal mandate to be vaccinated against covid, but the number who have done so is unknown.
Money Flows Into Addiction Tech, But Will It Curb Soaring Opioid Overdose Deaths?
Experts are concerned that flashy Silicon Valley technology won’t reach those most in need of treatment for substance use disorders.
Pfizer CEO Pushes Yearly Shots for Covid. Not So Fast, Experts Say.
A corporate CEO’s call for a fourth mRNA shot struck those closely watching the pandemic as self-serving. It creates public pressure for a fourth dose of vaccine before government experts have time to assess the evidence and settle on the best course forward.
KHN’s ‘What the Health?’: We May Be Done With Covid, But Covid’s Not Done With Us
The White House makes a move as a new wave of covid threatens. President Joe Biden brings in Dr. Ashish Jha to take over the executive branch effort. Meanwhile, it remains unclear if and when Congress can come up with the funds to continue much of the federal anti-covid effort. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sandhya Raman of CQ Roll Call, and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss these issues and more.
It Was Already Hard to Find Evusheld, a Covid Prevention Therapy. Now It’s Even Harder.
At least 7 million immunocompromised people could benefit from the monoclonal antibody injections designed to prevent covid-19. The government says it has enough doses for a fraction of those in need ― and it doesn’t have the money to buy more.
Covid’s ‘Silver Lining’: Research Breakthroughs for Chronic Disease, Cancer, and the Common Flu
Billions of dollars invested in mRNA vaccines and covid research could yield health care dividends for decades to come.
Long Waits for Montana State Hospital Leave Psychiatric Patients in Jail
A backlog at Montana’s psychiatric hospital for those facing criminal charges has left people with serious mental illness behind bars for months without adequate treatment. In some cases, judges have freed defendants over due-process violations.
Pandemic Medical Innovations Leave Behind People With Disabilities
As the country enters Year 3 of the pandemic emergency, people with disabilities across the U.S. are still finding it difficult to use innovations in telemedicine, teleworking, and testing.
KHN’s ‘What the Health?’: Congress Shelves Covid Funding for Now
The Biden administration’s request for billions more in funding to fight covid-19 hit a snag on Capitol Hill this week, as Democrats objected to Republican demands that money allocated to states but not yet spent be reclaimed. Meanwhile, the big annual spending bill about to cross the finish line addresses other health policy changes, such as giving the FDA authority to regulate “synthetic” nicotine. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Cohrs of Stat, and Jessie Hellmann of Modern Healthcare join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
Two Years In, Covid Leaves Montana Public Health Officials Feeling ‘Watched’
Montanans engage in plenty of spirited political disagreements. But debates about covid-19, public health, and personal liberties have reached a fever pitch, tugging at tightknit towns and making some residents wonder how their communities will survive.
One California University Has Unified Town and Gown to Fight Covid. Why Haven’t Others?
The University of California-Davis has spent close to $50 million preventing the spread of covid on campus — and among residents and workers in the adjacent city of Davis. By most accounts, this town-gown experiment has paid off nicely.
The NFL Has Been Using an Unproven Measure to Get Players With Covid Back on the Field Fast
Doctors and scientists are debating whether a little-known measure in covid testing should be used to distinguish who is infectious from who isn’t. The NFL adopted the practice, but laboratory professionals caution against its use.
Charts Paint a Grim Picture 2 Years Into the Coronavirus Pandemic
The on-off nature of the pandemic “has led to a lot of the confusion and grumpiness,” says one expert. Another compares it to the exhaustion of the American public when hearing body counts during the Vietnam War.
Watch: California’s Top Health Adviser on Learning to Live With Covid
KHN Senior Correspondent Samantha Young joined California Health and Human Services Secretary Mark Ghaly for an engaging conversation about how California moves forward in an environment in which covid persists, but at more manageable levels.
When Teens Blow Off Parents’ Pleas to Get Vaccinated, the Consequences Can Be Deadly
Kennedy Stonum, a 17-year-old high school junior, resisted getting vaccinated against covid-19, as did 20-year-old Tyler Gilreath, whose mother had nagged him for months to get the shots. Both died.
To Be One in a Million: ‘Who Thinks It’s Going to Be You?’
Stan Thomas’ wife, Monica Melkonian, was one of only nine people in the U.S. confirmed to have died from vaccine-induced immune thrombotic thrombocytopenia, a rare side effect associated with the Johnson & Johnson covid vaccine. For the first time, Thomas shares her story of how excited she was to get the shot, how she died, and why he remains firmly pro-vaccine.
Covid Expert Joins Exodus Into Business, Where Science Parlays Into Profits
Like others in academia or government who’ve served as public health advisers during the pandemic, Dr. Michael Mina traded his university role for a commercial venture. He recently took a top job at eMed, a startup that charges a premium price for monitoring at-home covid tests. Can experts do well by trying to do good?
From Alabama to Utah, Efforts to Vaccinate Medicaid Enrollees Against Covid Run Into Obstacles
Inoculation rates remain low despite massive outreach efforts and incentives from federal and state programs and Medicaid plan operators, leaving many low-income people vulnerable to the virus.
